Pancreatic Cancer Research

ResearcherUniversity of SaskatchewanActive in the last 2 years

Shahid Ahmed

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2099-698X; OpenAlex author ID A5012280033, A5035504233. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 7

  1. Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges. Last author DOI 10.3390/curroncol33080452↗
  2. Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use. Co-author DOI 10.3390/curroncol32030128↗
  3. Organoid Pharmacotyping of Pancreatic Cancer Enables Functional Precision Oncology and Drug Repurposing Co-author DOI 10.64898/2025.12.01.691211↗
  4. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial. Co-author DOI 10.1001/jamaoncol.2022.3829↗
  5. Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based… Last author DOI 10.1371/journal.pone.0263250↗
  6. Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy. Last author DOI 10.1007/s12029-020-00417-9↗
  7. Comparisons of Outcomes of Real-World Patients With Advanced Pancreatic Cancer Treated With FOLFIRINOX Versus Gemcitabine and Nab-Paclitaxel: A Population-Base… Last author DOI 10.1097/mpa.0000000000001340↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Franco J. Vizeacoumar · 2 shared papers, 2025–2026 · strength 0.56
  2. Ramy Habib · 1 shared paper, 2026 · strength 0.39
  3. Akmal Ghafoor · 1 shared paper, 2025 · strength 0.25
  4. Rachel Anne Goodwin · 1 shared paper, 2025 · strength 0.25
  5. Karen E. Mulder · 1 shared paper, 2025 · strength 0.25
  6. Petr Kavan · 1 shared paper, 2025 · strength 0.25
  7. Joanna Gotfrit · 1 shared paper, 2025 · strength 0.25
  8. Nicholas Jette · 1 shared paper, 2025 · strength 0.17
  9. He Dong · 1 shared paper, 2025 · strength 0.17
  10. Shaina D'Lee Templeton · 1 shared paper, 2021 · strength 0.14
  11. Javeria Muhammadzai · 1 shared paper, 2022 · strength 0.13
  12. Neha Papneja · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.